Occuity

08/09/2025

Occuity's ultimate vision is a BIG one - a future where a simple eye scan at your doctors, local optician or pharmacy could detect early signs of diabetes or Alzheimer’s — before the damage they cause appear as symptoms.

That’s the future we’re working towards with our grant-funded screening devices.

By targeting systemic diseases through the eye — a field known as Oculomics — we ar eworking to bring early detection into accessible, everyday healthcare settings. We believe prevention is better than cure.

These devices are the long-term future of Occuity, built on the same core optical technology as the PM1, AX1, and Indigo.

We’re raising now to accelerate this vision.

✅ Pre-register today for early access 👉 https://zurl.co/GxucN

Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more. https://zurl.co/2NXpQ

05/09/2025

Why is the exciting? Well, did you know that by 2050, over 50% of the global population is expected to be myopic?

Myopia is one of the biggest, fastest-growing eye health challenges of our time — and it’s particularly concerning problem for our children.

The AX1 Axiometer, is designed to meet this challenge head-on. A compact, handheld, non-contact device for measuring axial length of children — the key metric for effective myopia management.




Easy to use. Portable. Child-friendly.

The AX1 has already generated significant interest from distributors and global partners — including conversations with one of the biggest names in eye care in the UK.

It’s our most commercially exciting product to date — and you can be part of its journey to market.

Do some research and then regsiter for early access on Crowdcube.

✅ Pre-register today for early access 👉 https://zurl.co/e6XZx

Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more. https://zurl.co/ALGyS

04/09/2025

We're . But why should you invest in Occuity?

Because you believe, as we do that a simple scan of the eye could help improve the lives of hundreds of millions of people.

From and to and ’s — our handheld, non-invasive devices aim to revolutionise the way chronic diseases are screened and monitored. No blood. No needles. No discomfort. Just light.

We’ve already launched our first product the PM1 Pachymeter, and built a strong patent portfolio. Now, we working on a breakthrough myopia device due to launch in 2026, the opportunity has never been greater.

Join us as we build the future of preventative healthcare.

✅ Pre-register today for early acces on Crowdcube 👉 https://zurl.co/LOxoV

Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more. https://zurl.co/nDZrZ

03/09/2025

Exciting News!! We’re pleased to announce that Occuity is launching a new crowdfunding campaign on leading platform Crowdcube - and we're giving you, early access.

Occuity’s bold mission is to improve the lives of millions by transforming how we screen and monitor some of the world’s most prevalent chronic diseases — including myopia, diabetes, and Alzheimer’s.

By harnessing the power of light we're using the eye as a window to systemic health, and are developing a platform of handheld, non-contact devices that offer fast, pain-free diagnostics — without needles, blood, or discomfort.

If you share our vision — and are looking for an ethical, future-focused investment opportunity with the potential for significant value creation — this is your chance to join us.

✅ Campaign launching on Crowdcube soon!
✅ Invest from as little as £30
✅ Pre-register today for early access 👉 https://zurl.co/W4xHn

Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more. https://zurl.co/UVx9J

24/07/2025

We're proud to share that Occuity has been recognised as part of a landmark £6 billion UK-India trade announcement, highlighting our recent collaboration with leading Indian medtech company Remidio.

Our partnership is focused on expanding access to our innovative eye health technologies — including the PM1 Pachymeter and upcoming AX1 Axiometer™ — in one of the world’s fastest-growing healthcare markets.

This recognition reinforces our mission to improve access to high-quality, non-invasive diagnostics worldwide, starting with India.

Occuity Recognised in Landmark £6 billion UK-India Trade Announcement

11/06/2025

💬 How much does myopia management cost in the UK & Ireland? We're building a clearer picture. If you offer myopia treatments, take 2 minutes to share your pricing insight.



https://zurl.co/4OEXQ

13/02/2025

💡 China has reclassified Red Light Therapy for myopia, meaning existing treatments are no longer approved.

But what does this mean for RLRL therapy? 🌍👓

How will this impact impact global myopia treatment options? Our latest blog explores what’s really happening.

📖 Read the full article here: https://zurl.co/Hh6hA

💬 If you're an ECP - What do you think? Should red light therapy face tighter scrutiny or wider acceptance? Let us know your thoughts...Join the conversation below! ⬇️

As pointed out many times on this and other websites, myopia is an increasingly common global health issue. Although therapies exist to slow the progression of myopia, there is a large growing body of evidence showing a huge rise in the prevalence of the condition. The visual prognosis for many high...

27/01/2025

Exciting news! 🎉 Occuity is delighted to announce our partnership with Abioz Technologies as our exclusive distributor in France. This collaboration marks a significant step in making our innovative non-invasive optical technologies more accessible across Europe. 🌍

Read more here: https://zurl.co/OQWnk

19/12/2024

ANNOUNCEMENT

If you have been following our journey, you might want to know that Occuity is closing it's current investment round tomorrow - Friday, 20th December 2024. If you wish to take advantage of investing in this round before it closes, please visit https://zurl.co/3CMR5 .

- The minimum investment is £5,016 (209 Shares).
- Before you complete the application form, please ensure you have completed the HNW/Sophisticated Investor Self-certification, and Investor Verification within the last 12 months - (click here).

If you have any problems with these or have any questions, please email marketing@occuity.com

11/12/2024

🚀 Exciting News from Occuity!
We’re proud to announce Von Hoff as our exclusive distributor for the PM1 Pachymeter and AX1 Axiometer in Switzerland and Liechtenstein. With CE certification now achieved, the PM1 brings revolutionary non-contact technology to glaucoma screening and corneal diagnostics.

Mark Jenkins, COO of Occuity, said: "Partnering with Von Hoff is fantastic news. Their expertise and commitment to innovation will be instrumental in bringing our products to clinicians and patients across the region."

👉 Read the full announcement here https://zurl.co/ITQTy

Occuity, a UK-based leader in non-contact handheld medical devices, is pleased to announce the appointment of Von Hoff as the exclusive distribution partner for its ophthalmic product line, including the PM1 Pachymeter and AX1 Axiometer, in Switzerland and Liechtenstein. This partnership marks anoth...

13/11/2024

🌟 Lighting Up Occuity! 🌟

We recently celebrated Diwali, the Festival of Lights, at Occuity with decorations, traditional Indian treats, and plenty of laughter! 🎉 Our multicultural team, with members from the UK, Iran, Egypt, India, and across Europe, embraced this beautiful occasion together, enjoying a vibrant spread of pani puri, kaju katli, and jalebi. 🥘✨

Celebrating diverse traditions like Diwali brings us closer, sparks new conversations, and reminds us of the joy of working together. Read our latest blog to see how we light up our workplace culture.

https://zurl.co/ZPsw

Diwali, also known as the Festival of Lights, is one of the most significant festivals in India, celebrated by millions of people around the world. It symbolises the victory of light over darkness and good over evil, commemorating the return of Lord Rama to his kingdom after defeating the demon king...

04/11/2024

In this video, Optometrist, Jason Higginbotham, introduces the PM1 Pachymeter, the world's first handheld, non-contact optical pachymeter. Jason demonstrates what is included with the device, how to set it up and how to take corneal centre thickness (CCT) measurements quickly and effectively. He provides some best practice advice and offers some hints and tips.

https://zurl.co/hY6O

Please Note:
This video is intended for information purposes only. We advise you to read the PM1's 'Instructions For Use' manual before operating the device.

In this video, Optometrist, Jason Higginbotham, introduces the PM1 Pachymeter, the world's first handheld, non-contact optical pachymeter. Jason demonstrates...